DK152744C - Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat - Google Patents

Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat

Info

Publication number
DK152744C
DK152744C DK365282A DK365282A DK152744C DK 152744 C DK152744 C DK 152744C DK 365282 A DK365282 A DK 365282A DK 365282 A DK365282 A DK 365282A DK 152744 C DK152744 C DK 152744C
Authority
DK
Denmark
Prior art keywords
units
preparation
controlled release
pharmaceutical
active substance
Prior art date
Application number
DK365282A
Other languages
English (en)
Other versions
DK365282A (da
DK152744B (da
Inventor
Stig Roswall
Lene Birgitte Thorhus
Original Assignee
Benzon As Alfred
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Benzon As Alfred filed Critical Benzon As Alfred
Priority to DK365282A priority Critical patent/DK152744C/da
Priority to AT83304583T priority patent/ATE65181T1/de
Priority to DE198383304583T priority patent/DE106443T1/de
Priority to EP83304583A priority patent/EP0106443B1/en
Priority to DE8383304583T priority patent/DE3382341D1/de
Priority to AU17854/83A priority patent/AU1785483A/en
Priority to CA000434484A priority patent/CA1218305A/en
Priority to NO832895A priority patent/NO832895L/no
Priority to FI832909A priority patent/FI832909A/fi
Priority to JP58148684A priority patent/JPS5962521A/ja
Priority to US06/523,635 priority patent/US4574080A/en
Publication of DK365282A publication Critical patent/DK365282A/da
Publication of DK152744B publication Critical patent/DK152744B/da
Application granted granted Critical
Publication of DK152744C publication Critical patent/DK152744C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK365282A 1982-08-13 1982-08-13 Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat DK152744C (da)

Priority Applications (11)

Application Number Priority Date Filing Date Title
DK365282A DK152744C (da) 1982-08-13 1982-08-13 Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat
AT83304583T ATE65181T1 (de) 1982-08-13 1983-08-09 Pharmazeutische orale formulierung mit mehrfachen einheiten, mit kontrollierter freisetzung.
DE198383304583T DE106443T1 (de) 1982-08-13 1983-08-09 Pharmazeutische orale formulierung mit mehrfachen einheiten, mit kontrollierter freisetzung.
EP83304583A EP0106443B1 (en) 1982-08-13 1983-08-09 Pharmaceutical oral-controlled release multiple-units formulation
DE8383304583T DE3382341D1 (de) 1982-08-13 1983-08-09 Pharmazeutische orale formulierung mit mehrfachen einheiten, mit kontrollierter freisetzung.
AU17854/83A AU1785483A (en) 1982-08-13 1983-08-10 Slow release and fast release tablet formulation comprising two active ingredients
CA000434484A CA1218305A (en) 1982-08-13 1983-08-12 Combination formulation
NO832895A NO832895L (no) 1982-08-13 1983-08-12 Fremgangsmaate for fremstilling av et farmasoeytisk preparat med regulert frigivning av aktiv substans
FI832909A FI832909A (fi) 1982-08-13 1983-08-12 Farmaceutisk kombinationspreparat och foerfarande foer framstaellning daerav
JP58148684A JPS5962521A (ja) 1982-08-13 1983-08-13 医薬用の経口放出調整複合単位製剤とその製法
US06/523,635 US4574080A (en) 1982-08-13 1983-08-15 Combination formulation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK365282 1982-08-13
DK365282A DK152744C (da) 1982-08-13 1982-08-13 Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat

Publications (3)

Publication Number Publication Date
DK365282A DK365282A (da) 1984-02-14
DK152744B DK152744B (da) 1988-05-09
DK152744C true DK152744C (da) 1988-10-31

Family

ID=8125282

Family Applications (1)

Application Number Title Priority Date Filing Date
DK365282A DK152744C (da) 1982-08-13 1982-08-13 Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat

Country Status (10)

Country Link
US (1) US4574080A (da)
EP (1) EP0106443B1 (da)
JP (1) JPS5962521A (da)
AT (1) ATE65181T1 (da)
AU (1) AU1785483A (da)
CA (1) CA1218305A (da)
DE (2) DE106443T1 (da)
DK (1) DK152744C (da)
FI (1) FI832909A (da)
NO (1) NO832895L (da)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
DE3305935C2 (de) * 1983-02-21 1985-05-30 Medice Chem.-Pharm. Fabrik Pütter GmbH & Co KG, 5860 Iserlohn Kaliumneutrales Saluretikum mit antihypertensiver Wirkung
IE59287B1 (en) * 1984-02-10 1994-02-09 Benzon Pharma As Diffusion coated multiple-units dosage form
NL8401362A (nl) * 1984-04-27 1985-11-18 Tno Werkwijze voor het met een polymeer omhullen van deeltjesvormige materialen teneinde de gereguleerde afgifte van deze materialen aan de omgeving mogelijk te maken alsmede aldus verkregen omhuld deeltjesvormig materiaal.
JPS618A (ja) * 1984-06-09 1986-01-06 Sawai Seiyaku Kk ニフエジピン含有製剤
DE3431861A1 (de) * 1984-08-30 1986-03-13 Troponwerke GmbH & Co KG, 5000 Köln Pellet-zubereitung
DE3500103C2 (de) * 1985-01-04 1987-01-22 R.P. Scherer GmbH, 6930 Eberbach Pharmazeutische Zubereitung mit einem in Wasser und Verdauungssäften schwer löslichen Wirkstoff
US5229132A (en) * 1985-02-22 1993-07-20 Grimberg Georges Serge Non-absorbable gastrointestinal medicament provided for treating the two levels of the digestive tract at the same time
NL8500724A (nl) * 1985-03-13 1986-10-01 Univ Groningen Inrichtingen voor geregelde afgifte van werkzame stoffen, alsmede werkwijze ter vervaardiging daarvan.
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
GB8521494D0 (en) * 1985-08-29 1985-10-02 Zyma Sa Controlled release tablet
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
US4822619A (en) * 1987-02-18 1989-04-18 Ionor, Inc. Controlled release pharmaceutical preparation containing a gastrointestinal irritant drug
DE3814532A1 (de) * 1988-04-29 1989-11-09 Bayer Ag Dhp-retard-zubereitung
DE3822095A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Neue arzneimittelformulierung sowie verfahren zu deren herstellung
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
DE3941703C2 (de) * 1989-12-18 2002-11-07 Sanol Arznei Schwarz Gmbh Bumetanid enthaltende pharmazeutische Zubereitung
US5876752A (en) * 1990-08-07 1999-03-02 Pfizer Inc. Use of interfacially-polymerized membranes in delivery devices
US5252337A (en) * 1991-06-25 1993-10-12 Eurand America, Inc. Controlled release calcium channel blocker microcapsules
KR100221695B1 (ko) * 1991-08-12 1999-09-15 그린 마틴, 브라이언 쥐 테슬리 약학적 구상 제형
GB9117361D0 (en) * 1991-08-12 1991-09-25 Euro Celtique Sa Oral dosage form
JP2835796B2 (ja) * 1992-02-06 1998-12-14 メルク・ジヤパン株式会社 新規な薄片状顔料
PT571973E (pt) * 1992-05-29 2000-05-31 Nikken Chemicals Co Ltd Comprimidos de valproato de sodio de libertacao retardada
US5422122A (en) * 1992-08-04 1995-06-06 Eurand America, Incorporated Controlled release potassium chloride tablet
US5397574A (en) * 1993-10-04 1995-03-14 Andrx Pharmaceuticals, Inc. Controlled release potassium dosage form
US6149953A (en) * 1993-11-08 2000-11-21 Delta Food Group, Inc. Seeded microcapsules
BE1009257A3 (nl) * 1995-03-21 1997-01-07 Universiteit Gent Lab Voor Far Farmaceutische matrix.
US5674529A (en) * 1995-06-06 1997-10-07 Church & Dwight Co., Inc. Alkalinizing potassium salt controlled release preparations
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
ES2328191T3 (es) * 1997-03-14 2009-11-10 Toray Industries, Inc. Preparacion de derivado de la prostaglandina i de liberacion sostenida.
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
US20020054911A1 (en) * 2000-05-11 2002-05-09 Boehringer Mannheim Pharmaceutical Corporation-Sm Ithkline Beckman Corporation, Limited Partnershi Novel oral dosage form for carvedilol
JPH11269064A (ja) * 1998-03-20 1999-10-05 Kowa Co 胃・十二指腸付着性医薬組成物
SE9803240D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
DE19921549A1 (de) * 1999-05-11 2000-11-16 Merck Patent Gmbh Mahlhilfsmittel für die Röntgenfluoreszenzanalyse
US6428809B1 (en) * 1999-08-18 2002-08-06 Microdose Technologies, Inc. Metering and packaging of controlled release medication
SE9903236D0 (sv) * 1999-09-10 1999-09-10 Astra Ab Method to obtain microparticles
US20060159756A1 (en) * 1999-09-10 2006-07-20 Brita Sjoblom Method to obtain microparticles containing an H+,K+-ATP-ASE inhibitor
DE60128910T2 (de) 2000-04-27 2008-02-28 Verion Inc. Nullte-ordnung-freisetzung und temperatur-kontrollierte mikrokapseln sowie herstellungsverfahren
US6958161B2 (en) 2002-04-12 2005-10-25 F H Faulding & Co Limited Modified release coated drug preparation
JP2006500395A (ja) * 2002-09-09 2006-01-05 エンド ファーマシューティカルズ インコーポレーテッド 組み合わされた即時放出及び徐放の鎮痛組成物
EP1572190B1 (en) * 2002-12-17 2007-04-18 Abbott GmbH & Co. KG Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof
US20080051411A1 (en) * 2002-12-17 2008-02-28 Cink Russell D Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
US7259186B2 (en) * 2002-12-17 2007-08-21 Abbott Laboratories Salts of fenofibric acid and pharmaceutical formulations thereof
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
FR2861990B1 (fr) * 2003-11-10 2006-02-10 Nouveaux Produits Pharma Comprimes faiblement doses a reseau de polymeres
PL1591109T3 (pl) * 2004-04-30 2008-11-28 Topotarget Germany Ag Preparat zawierający inhibitor deacetylazy histonów wykazujący dwufazowe uwalnianie”
CN1964703B (zh) * 2004-05-21 2012-07-04 阿库-伯雷克技术公司 高度超过宽度的速释药片
EP1748761A4 (en) * 2004-05-27 2011-10-12 Dexcel Pharma Technologies Ltd REGULATED AND LOCALIZED ABSORPTION OF STATINS IN THE GASTROINTESTINAL TRACT TO OBTAIN HIGH BLOOD RATE OF STATINS
GB0423800D0 (en) * 2004-10-27 2004-12-01 Orexo Ab New pharmaceutical formulations
US20080152714A1 (en) * 2005-04-08 2008-06-26 Yi Gao Pharmaceutical Formulations
JP5259413B2 (ja) * 2005-11-18 2013-08-07 エーシーシーユー−ブレイク テクノロジーズ，インク． セグメント化した薬の剤形
SI2040684T1 (sl) * 2006-07-11 2013-06-28 Lek Pharmaceuticals D.D. Večenotne tablete
US8241661B1 (en) * 2011-06-24 2012-08-14 Fuisz Richard C Biocompatible film with variable cross-sectional properties
EP2674153B1 (en) * 2012-06-14 2016-08-10 ratiopharm GmbH Oral dosage form for the immediate release of bendroflumethiazide and controlled release of a second active agent
CA2936741C (en) 2014-10-31 2018-11-06 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3538214A (en) * 1969-04-22 1970-11-03 Merck & Co Inc Controlled release medicinal tablets
DE2031871C3 (de) * 1970-06-27 1974-06-27 Roehm Gmbh, 6100 Darmstadt Überzugsmasse für Arzneiformen
US3873346A (en) * 1970-12-23 1975-03-25 Us Interior Process of forming self-destructing pesticidal formulations
US3909444A (en) * 1971-08-05 1975-09-30 Ncr Co Microcapsule
GB1468172A (en) * 1973-03-28 1977-03-23 Benzon As Alfred Oral drug preparations
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
FR2397840B1 (da) * 1977-07-22 1981-03-20 Cherqui Jean
DE2849494A1 (de) * 1978-11-15 1980-05-29 Voss Gunter M Verfahren zur herstellung von arzneimittel-formlingen
US4173626A (en) * 1978-12-11 1979-11-06 Merck & Co., Inc. Sustained release indomethacin
US4221778A (en) * 1979-01-08 1980-09-09 Pennwalt Corporation Prolonged release pharmaceutical preparations
US4316884A (en) * 1979-01-25 1982-02-23 Adria Laboratories, Inc. Sustained release pharmaceutical formulation
US4353887A (en) * 1979-08-16 1982-10-12 Ciba-Geigy Corporation Divisible tablet having controlled and delayed release of the active substance
JPS5911563B2 (ja) * 1980-02-27 1984-03-16 日本原子力研究所 多層構造の徐放性複合体を製造する方法
JPS56152739A (en) * 1980-04-25 1981-11-26 Tanabe Seiyaku Co Ltd Production of microcapsule
US4259315A (en) * 1980-06-13 1981-03-31 A. H. Robins Company, Inc. Controlled release potassium dosage form

Also Published As

Publication number Publication date
JPS6238323B2 (da) 1987-08-17
DE3382341D1 (de) 1991-08-22
US4574080A (en) 1986-03-04
DK365282A (da) 1984-02-14
FI832909A0 (fi) 1983-08-12
JPS5962521A (ja) 1984-04-10
EP0106443B1 (en) 1991-07-17
EP0106443A2 (en) 1984-04-25
ATE65181T1 (de) 1991-08-15
EP0106443A3 (en) 1985-11-27
DK152744B (da) 1988-05-09
FI832909A (fi) 1984-02-14
DE106443T1 (de) 1984-09-13
AU1785483A (en) 1984-02-16
NO832895L (no) 1984-02-14
CA1218305A (en) 1987-02-24

Similar Documents

Publication Publication Date Title
DK152744C (da) Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat
EE9700176A (et) Kuivpulbriinhalaatorites kasutatav pulber, selle valmistamismeetod, selles kasutatavad osakesed ja meetod nende valmistamiseks ning pulbri lisandi kasutamine
DK28480A (da) Fremgangsmaade til fremstilling af tabletter med forsinket frigivelse af det aktive middel i hvilke tabletter frigivelseshastigheden for det aktive middel er fastlagt i forvejen
MY101544A (en) Pharmaceutical composition for external use containing active-type vitamin d3.
ATE47520T1 (de) Darmloesliche ueberzugsmasse fuer pharmazeutische verabreichungsformen.
NO834052L (no) Enterisk belegg for farmasoeytiske doseringsformer
DE3771091D1 (de) Formulierung mit langsamer freisetzung.
DK0526606T3 (da) Forbedringer i eller ved elektrostatisk coatning af substrater af medicinske produkter
IT1200424B (it) Fosforo rosso stabilizzato per uso come ritardante di fiamma,particolarmente per composizioni a base di polimeri
HUP9902673A2 (hu) Transzdermális terápiás rendszer csekély alkalmazási vastagsággal és nagymértékű rugalmassággal, valamint eljárás az előállításhoz
JPS57112334A (en) Particles of lipid soluble substance, composition consisting of particles and biologically active substance adsorbed with particles and their manufacture
ES8303088A1 (es) Procedimiento para la obtencion de una forma retardada de medicamento granulado.
ES8402720A1 (es) Procedimiento para la obtencion de una composicion a base de estireno para revestir alimentos y medicamentos.
NO884530D0 (no) Plaster med aktive stoffer for styrt avgivelse av aktive stoffer til huden, anvendelse saavel som fremgangsmaate for styrt avgivelse av aktive stoffer til huden.
ES531434A0 (es) Procedimiento para el recubrimiento de sustratos mediante aplicacion del recubrimiento en forma de pelicula y posterior ahornado.
DK231683D0 (da) Fremgangsmade til fremstilling af celle-og vaevsregenererende stoffer
DE3678641D1 (de) Partikel mit konstanter wirkstofffreisetzung.
PT74654A (pt) Process for the preparation of compositions in powder form containing pesticides and suitable for treatment of house hold furnishing
DK275582A (da) Depotorgan til frigivelse af biologisk aktive stoffer til fordoejelseskanalen samt fremgangsmaade til anvendelse heraf
JPS52125630A (en) Antiperkinson drugs containing l-threo-3,4-dihydroxyphenylserine
JPS57142913A (en) Donor of physiologically active substance
JPS6485911A (en) Plaster
JPS5659707A (en) Lasting antibiotic pharmaceutical and its preparation
JPS54126722A (en) Slow release antibiotic tablet
JPS5367706A (en) Method of cleaning and cleaning agent

Legal Events

Date Code Title Description
PBP Patent lapsed